Company intelligence / Profile preview

Anhui Dendrobium Huoshan Industrial Development Collaborative Innovation Center

Huoshan County, Anhui, China

Ownership: Private
Development stage: Other

Overview

Dendrobium-based formulas from Huoshan are clinically observed to alleviate oral mucositis during cancer therapy by modulating EGFR/PI3K/AKT and inflammatory processes, with patent application underway; most activities focus on herbal material production, quality evaluation, and integration into TCM practice, not classical biotech pipeline drugs.

Therapeutic areas: ImmunologyMetabolic DisordersRheumatologyDermatologyOncologyNeurology
Modalities: Plant-derived natural productsHerbal medicineSmall molecule
Industry: Agriculture & AgTech

Partnerships

Anhui University of Chinese MedicineWest Anhui UniversityXinxiang Medical University

Beyond the preview

Go deeper on Anhui Dendrobium Huoshan Industrial Development Collaborative Innovation Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anhui Dendrobium Huoshan Industrial Development Collaborative Innovation Center.

Explore the full profile